Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.
2.
3.

Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA.

Arch Neurol. 2003 Aug;60(8):1119-22.

PMID:
12925369
4.
5.

Recognition memory in Alzheimer's disease. A demonstration of a remarkable memory capacity in Alzheimer's disease.

Karlsson T, Johansson I, Adolfsson R, Nilsson LG, Dubuc S.

Dement Geriatr Cogn Disord. 2003;15(1):6-9.

PMID:
12457073
6.

Current state of research on decision-making competence of cognitively impaired elderly persons.

Kim SY, Karlawish JH, Caine ED.

Am J Geriatr Psychiatry. 2002 Mar-Apr;10(2):151-65. Review.

PMID:
11925276
7.

The MacArthur Treatment Competence Study. II: Measures of abilities related to competence to consent to treatment.

Grisso T, Appelbaum PS, Mulvey EP, Fletcher K.

Law Hum Behav. 1995 Apr;19(2):127-48. No abstract available.

PMID:
11660291
8.

Consent to research with impaired human subjects: a trial policy for the intramural programs of the National Institutes of Health.

Fletcher JC, Dommel FW, Cowell DD.

IRB. 1985 Nov-Dec;7(6):1-6. No abstract available.

PMID:
11649686
9.

Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.

Kim SY, Caine ED, Currier GW, Leibovici A, Ryan JM.

Am J Psychiatry. 2001 May;158(5):712-7.

PMID:
11329391
10.

Decisional capacity for informed consent in schizophrenia research.

Carpenter WT Jr, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS.

Arch Gen Psychiatry. 2000 Jun;57(6):533-8.

PMID:
10839330
11.

Treatment of Alzheimer's disease.

Mayeux R, Sano M.

N Engl J Med. 1999 Nov 25;341(22):1670-9. Review. No abstract available.

PMID:
10572156
12.

Competence of depressed patients for consent to research.

Appelbaum PS, Grisso T, Frank E, O'Donnell S, Kupfer DJ.

Am J Psychiatry. 1999 Sep;156(9):1380-4.

PMID:
10484948
13.

Do we have a treatment for Alzheimer disease? Yes.

Gauthier S.

Arch Neurol. 1999 Jun;56(6):738-9. Review. No abstract available.

PMID:
10369316
14.

Do we have drugs for dementia? No.

Pryse-Phillips W.

Arch Neurol. 1999 Jun;56(6):735-7. Review. No abstract available.

PMID:
10369315
15.
16.

Federal policy for the protection of human subjects. Final rule.

[No authors listed]

Fed Regist. 1991 Jun 18;56(117):28003-18.

PMID:
10112214
17.

Assessment of patient capacity to consent to treatment.

Etchells E, Darzins P, Silberfeld M, Singer PA, McKenny J, Naglie G, Katz M, Guyatt GH, Molloy DW, Strang D.

J Gen Intern Med. 1999 Jan;14(1):27-34.

18.

Guidelines for conducting bridging studies in Alzheimer disease.

Cutler NR, Sramek JJ.

Alzheimer Dis Assoc Disord. 1998 Jun;12(2):88-92.

PMID:
9651137
19.

Cognitive functions in the informed consent evaluation process: a pilot study.

Holzer JC, Gansler DA, Moczynski NP, Folstein MF.

J Am Acad Psychiatry Law. 1997;25(4):531-40.

PMID:
9460039
20.

Research on the cognitively impaired: lessons and warnings from the emergency research debate.

Karlawish JH, Sachs GA.

J Am Geriatr Soc. 1997 Apr;45(4):474-81. Review.

PMID:
9100718

Supplemental Content

Support Center